1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Helena Laboratories Corp. - Product Pipeline Analysis, 2016 Update

Summary
Helena Laboratories Corp. (Helena) is a medical device company that develops and distributes clinical laboratory instruments and reagents. The company’s products comprise electrophoresis analyzers, densitometers, electrophoresis supplies, hemostasis instruments, spife replacement pump, immunology and protein diagnostic products. It offers column chromatography supplies, disposable laboratory plasticware and test kits for fecal occult blood. Helena provides automated gel electrophoresis systems for serum proteins, immunofixation, and cholesterol and hemoglobin analysis. The company offers its products to medical centers, hospitals, reference laboratories and private doctor's laboratories. It distributes products through its distribution network in Algeria, Argentina, Austria, Bahrain, Bangladesh, Belgium, Brazil, China, Colombia, and Costa Rica. Helena is headquartered in Beaumont, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Helena Laboratories Corp.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Helena Laboratories Corp. - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Helena Laboratories Corp. Company Overview 7
Helena Laboratories Corp. Company Snapshot 7
Helena Laboratories Corp. Pipeline Products and Clinical Trials Overview 8
Helena Laboratories Corp. - Pipeline Analysis Overview 10
Key Facts 10
Helena Laboratories Corp. - Major Products and Services 11
Helena Laboratories Corp. Pipeline Products by Development Stage 12
Helena Laboratories Corp. Pipeline Products Overview 14
Actalyke Mini II - APTT Test 14
Actalyke Mini II - APTT Test Product Overview 14
Actalyke Mini II - LMWH Test 15
Actalyke Mini II - LMWH Test Product Overview 15
Actalyke Mini II - PT Test 16
Actalyke Mini II - PT Test Product Overview 16
Actalyke XL - APTT Test 17
Actalyke XL - APTT Test Product Overview 17
Actalyke XL - Heparin Test 18
Actalyke XL - Heparin Test Product Overview 18
Actalyke XL - LMWH Test 19
Actalyke XL - LMWH Test Product Overview 19
Actalyke XL - PT Test 20
Actalyke XL - PT Test Product Overview 20
AggRAM - Chromogenic Test 21
AggRAM - Chromogenic Test Product Overview 21
AggRAM - HIT Test 22
AggRAM - HIT Test Product Overview 22
AggRAM - Lumi Test 23
AggRAM - Lumi Test Product Overview 23
Cascade Abrazo - APTT 24
Cascade Abrazo - APTT Product Overview 24
Cascade Abrazo - c-ACT 25
Cascade Abrazo - c-ACT Product Overview 25
Cascade Abrazo - c-ACT-LR 26
Cascade Abrazo - c-ACT-LR Product Overview 26
Cascade Abrazo - Direct Thrombin Inhibitors 27
Cascade Abrazo - Direct Thrombin Inhibitors Product Overview 27
Cascade Abrazo - Fibrinogen 28
Cascade Abrazo - Fibrinogen Product Overview 28
Cascade Abrazo - Heparin Titration 29
Cascade Abrazo - Heparin Titration Product Overview 29
Cascade Abrazo - LMWH 30
Cascade Abrazo - LMWH Product Overview 30
Cascade Abrazo - Protamine Titration 31
Cascade Abrazo - Protamine Titration Product Overview 31
Cascade Abrazo - PT-C 32
Cascade Abrazo - PT-C Product Overview 32
Cascade Abrazo Analyzer 33
Cascade Abrazo Analyzer Product Overview 33
Cascade M - DRVVT Test 34
Cascade M - DRVVT Test Product Overview 34
Cascade M-4 - DRVVT Test 35
Cascade M-4 - DRVVT Test Product Overview 35
Cascade POC - Direct Thrombin Inhibitor Test 36
Cascade POC - Direct Thrombin Inhibitor Test Product Overview 36
Cascade POC - Fibrinogen Test 37
Cascade POC - Fibrinogen Test Product Overview 37
Helena Laboratories Corp. - Key Competitors 38
Helena Laboratories Corp. - Key Employees 39
Helena Laboratories Corp. - Locations And Subsidiaries 40
Head Office 40
Other Locations and Subsidiaries 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41


List of Tables
Helena Laboratories Corp. Pipeline Products and Clinical Trials Overview 8
Helena Laboratories Corp. Pipeline Products by Equipment Type 8
Helena Laboratories Corp. Pipeline Products by Indication 9
Helena Laboratories Corp., Key Facts 10
Helena Laboratories Corp., Major Products and Services 11
Helena Laboratories Corp. Number of Pipeline Products by Development Stage 12
Helena Laboratories Corp. Pipeline Products Summary by Development Stage 13
Actalyke Mini II - APTT Test - Product Status 14
Actalyke Mini II - APTT Test - Product Description 14
Actalyke Mini II - LMWH Test - Product Status 15
Actalyke Mini II - LMWH Test - Product Description 15
Actalyke Mini II - PT Test - Product Status 16
Actalyke Mini II - PT Test - Product Description 16
Actalyke XL - APTT Test - Product Status 17
Actalyke XL - APTT Test - Product Description 17
Actalyke XL - Heparin Test - Product Status 18
Actalyke XL - Heparin Test - Product Description 18
Actalyke XL - LMWH Test - Product Status 19
Actalyke XL - LMWH Test - Product Description 19
Actalyke XL - PT Test - Product Status 20
Actalyke XL - PT Test - Product Description 20
AggRAM - Chromogenic Test - Product Status 21
AggRAM - Chromogenic Test - Product Description 21
AggRAM - HIT Test - Product Status 22
AggRAM - HIT Test - Product Description 22
AggRAM - Lumi Test - Product Status 23
AggRAM - Lumi Test - Product Description 23
Cascade Abrazo - APTT - Product Status 24
Cascade Abrazo - APTT - Product Description 24
Cascade Abrazo - c-ACT - Product Status 25
Cascade Abrazo - c-ACT - Product Description 25
Cascade Abrazo - c-ACT-LR - Product Status 26
Cascade Abrazo - c-ACT-LR - Product Description 26
Cascade Abrazo - Direct Thrombin Inhibitors - Product Status 27
Cascade Abrazo - Direct Thrombin Inhibitors - Product Description 27
Cascade Abrazo - Fibrinogen - Product Status 28
Cascade Abrazo - Fibrinogen - Product Description 28
Cascade Abrazo - Heparin Titration - Product Status 29
Cascade Abrazo - Heparin Titration - Product Description 29
Cascade Abrazo - LMWH - Product Status 30
Cascade Abrazo - LMWH - Product Description 30
Cascade Abrazo - Protamine Titration - Product Status 31
Cascade Abrazo - Protamine Titration - Product Description 31
Cascade Abrazo - PT-C - Product Status 32
Cascade Abrazo - PT-C - Product Description 32
Cascade Abrazo Analyzer - Product Status 33
Cascade Abrazo Analyzer - Product Description 33
Cascade M - DRVVT Test - Product Status 34
Cascade M - DRVVT Test - Product Description 34
Cascade M-4 - DRVVT Test - Product Status 35
Cascade M-4 - DRVVT Test - Product Description 35
Cascade POC - Direct Thrombin Inhibitor Test - Product Status 36
Cascade POC - Direct Thrombin Inhibitor Test - Product Description 36
Cascade POC - Fibrinogen Test - Product Status 37
Cascade POC - Fibrinogen Test - Product Description 37
Helena Laboratories Corp., Key Employees 39
Helena Laboratories Corp., Subsidiaries 40

List of Figures
Helena Laboratories Corp. Pipeline Products by Development Stage 12

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent ...

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2016

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tissue ...

GenePOC Inc - Product Pipeline Analysis, 2016 Update

GenePOC Inc - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • December 2016
  • by GlobalData

Summary GenePOC Inc. (GenePOC) is a biomedical company which specializes in development of rapid molecular devices for providing targeted therapy for infectious diseases. It offers on-the-spot diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.